News
FDA clears Roche's Enspryng for thyroid eye disease
Roche has claimed US approval for Enspryng in a second indication, thyroid eye disease, that makes it a rival to drugs from Amgen and Viridian.
News
RevMed nears EU okay for pancreatic cancer drug Rasonque
Revolution Medicines is just weeks away from getting EU approval for its keenly anticipated oral RAS drug Rasonque for pancreatic cancer.
News
ImmunityBio bags elusive label extension for Anktiva
The FDA has handed ImmunityBio a key label extension for bladder cancer therapy Anktiva, giving it a leg-up on rival drug Inlexzo from J&J.
Sales & Marketing
Changing Faces: Agency, consultancy, and investor hires, Aug...
August and September brought leadership changes across healthcare communications, consulting, investment, and industry organisations.
News
GSK planning 1,200 job cuts in Belgium, says paper
GSK is said to be preparing to cut around 1,200 positions from its workforce in Belgium as part of a cost-saving programme launched by CEO Luke Miels.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
